Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Trust Co. of Vermont

Trust Co. of Vermont decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,095 shares of the medical equipment provider’s stock after selling 25 shares during the period. Trust Co. of Vermont’s holdings in Intuitive Surgical were worth $2,659,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the company. Sanibel Captiva Trust Company Inc. grew its position in Intuitive Surgical by 46.9% during the 4th quarter. Sanibel Captiva Trust Company Inc. now owns 930 shares of the medical equipment provider’s stock worth $485,000 after purchasing an additional 297 shares during the period. Howard Financial Services LTD. lifted its stake in shares of Intuitive Surgical by 4.0% in the 4th quarter. Howard Financial Services LTD. now owns 837 shares of the medical equipment provider’s stock valued at $437,000 after purchasing an additional 32 shares during the period. Arkadios Wealth Advisors boosted its holdings in Intuitive Surgical by 9.2% during the fourth quarter. Arkadios Wealth Advisors now owns 14,533 shares of the medical equipment provider’s stock worth $7,586,000 after buying an additional 1,229 shares in the last quarter. TrueWealth Advisors LLC grew its position in Intuitive Surgical by 27.1% during the fourth quarter. TrueWealth Advisors LLC now owns 1,037 shares of the medical equipment provider’s stock valued at $541,000 after buying an additional 221 shares during the period. Finally, Arthur M. Cohen & Associates LLC increased its holdings in Intuitive Surgical by 5.3% in the fourth quarter. Arthur M. Cohen & Associates LLC now owns 10,340 shares of the medical equipment provider’s stock valued at $5,397,000 after buying an additional 522 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This represents a 26.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock valued at $25,012,927 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $8.56 during mid-day trading on Friday, hitting $592.64. The stock had a trading volume of 2,630,118 shares, compared to its average volume of 1,158,623. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The company’s 50-day simple moving average is $539.54 and its 200-day simple moving average is $497.69. The firm has a market cap of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ISRG. Wells Fargo & Company raised their target price on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.